HBK INVESTMENTS L P - THERAVANCE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 16 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2022$44,830,000
+17.5%
48,455,000
+21.3%
0.25%
+58.8%
Q1 2022$38,147,000
+15.5%
39,945,000
+16.8%
0.16%
+30.1%
Q4 2021$33,023,000
+58.5%
34,195,000
+52.0%
0.12%
+50.0%
Q3 2021$20,832,000–22,500,000–0.08%–
 Download
Other shareholders

There were no reported owners of THERAVANCE BIOPHARMA INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of THERAVANCE BIOPHARMA INC shareholders